Viewing Study NCT00947193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2026-06-02 @ 9:42 AM
Study NCT ID: NCT00947193
Status: TERMINATED
Last Update Posted: 2020-06-16
First Post: 2009-07-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Ataluren (PTC124) in Hemophilia A and B
Sponsor: PTC Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia A View
None Hemophilia B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hemophilia A View
None Hemophilia B View
None Factor VIII View
None Factor IX View
None FVIII View
None FIX View
None Nonsense mutation View
None Premature stop codon View
None HA View
None HB View
None PTC124 View
None Ataluren View